{
    "Trade/Device Name(s)": [
        "cobas\u00ae HSV 1 and 2 Test"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K150617",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103798"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "March 9, 2015",
    "Summary Letter Received Date": "March 10, 2015",
    "Submission Date": "February 27, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Nucleic Acid Amplification Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Herpes simplex virus 1 DNA",
        "Herpes simplex virus 2 DNA"
    ],
    "Specimen Type(s)": [
        "External anogenital lesion swab specimens"
    ],
    "Specimen Container(s)": [
        "MSwab Collection, Transport and Preservation System (Copan Flock Technologies)"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 4800 system",
        "cobas\u00ae x 480 instrument",
        "cobas\u00ae z 480 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time polymerase chain reaction (PCR)",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "Qualitative real-time PCR detection",
        "Automated sample preparation",
        "TaqMan\u00ae probe-based PCR"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Reagent",
        "Control",
        "Kit",
        "System",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for cobas\u00ae HSV 1 and 2 Test, a qualitative real-time PCR assay for detection and differentiation of HSV-1 and HSV-2 DNA in external anogenital lesion specimens on the cobas\u00ae 4800 system",
    "Indications for Use Summary": "Qualitative detection and differentiation of HSV-1 and HSV-2 DNA in clinician-collected external anogenital lesion specimens from symptomatic patients, as an aid in diagnosing anogenital HSV-1 and HSV-2 infections; not cleared for cerebrospinal fluid, prenatal screening, or use in individuals under 18 years.",
    "fda_folder": "Microbiology"
}